Publication | Closed Access
Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS †
14
Citations
0
References
2018
Year
Compass †Pancreatic Fluid CollectionPharmacologyGastroenterologyMedicineReduced TriglyceridesShtg Vs Placebo
No additional data available for this publication yet. Check back later!